Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

5-Minute heart scan could slash ER overcrowding and save billions

NCT ID NCT07074808

Diagnosis Sponsor: Singapore General Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a portable AI device called aiTriage that analyzes heart rate, blood pressure, and oxygen levels in just 5 minutes. Over 1,100 adults with chest pain in the emergency department took part. The goal was to see if the device's real-time risk score could safely reduce unnecessary hospital admissions while still catching serious heart problems.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

1,120 people

The number who actually took part.

Started

Nov 2022

Finished

Dec 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All ED patients (≥21 years old) with chest pain suspected of having ACS will be eligible for being included in this study. Exclusion Criteria: * Patients who are not in sinus rhythm * Patients who do not have mental capacity. * Patients with unstable vital signs, STEMI, obvious ACS, and non cardiac cases like rib fractures, pneumothorax. * Patients lost to follow- up or transferred to other hospitals within the 30 day time frame. * Patients with a high percentage of artefacts and ectopics exceeding 30% of ECG recordings will be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chest pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Chest Pain Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chest pain Emergencies

Contacts and locations

Locations

  • National University Hospital

    Singapore, 119074, Singapore

  • Singapore General Hospital

    Singapore, 169608, Singapore

More trials for these conditions

Other studies related to the condition(s) this trial covers.